Endocrine Society's diabetes tool, diversity programs earn top honors in ASAE 2015 Power of A Awards

NewsGuard 100/100 Score

An Endocrine Society-led diabetes initiative's interactive tools earned top honors and two other Society programs won Silver in the ASAE 2015 Power of A Awards, the Society announced today.

The Accurate Insulin Decisions (AID) program, developed by the Endocrine Society and six other health care organizations, won the Power of A Gold Award. AID created a smartphone app and other decision support tools to help people with diabetes and their physicians to set realistic blood sugar goals and easily adjust their insulin dosage.

The AID program is a joint initiative of the Endocrine Society, American Diabetes Association, American Association of Diabetes Educators, American College of Physicians, American Osteopathic Association, American Pharmacists Association and Diabetes Nation. The program is supported by educational grants from Lilly USA, LLC; Novo Nordisk Inc.; and sanofi-aventis U.S.

The Power of A Awards showcase how associations leverage their unique resources to solve problems, advance industry/professional performance, kick-start innovation and improve world conditions. The judging committee selected 30 Gold Award winners and 31 Silver Award winners from among more than 140 entries. The Society was among one of two associations that received three Power of A Awards this year.

ASAE bestowed Power of A Silver Awards on the Society's diabetes policy summit ACA Implementation: Impact on the Patient with Diabetes and its EndoCareers Diversity programs, which promote the participation, visibility and advancement of underrepresented minorities in the endocrinology field.

The EndoCareers Diversity programs seek to enhance cultural diversity in the endocrinology field and offer internship opportunities to students from underrepresented minority groups. The Society's Future Leaders Advancing Research in Endocrinology (FLARE) Internship Awards provide training and professional development opportunities for underrepresented minority senior graduate students, postdoctoral and clinical research fellows in hormone health research. The program has accepted 45 participants in its first three years. FLARE is sponsored by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (DK096937).

For undergraduate students exploring educational and career opportunities, EndoCareers offers the Minority Access Program (MAP). During the two-year summer internship program, interns train in endocrine research labs and participate in professional development activities. More than 80 students have been accepted into the program and placed in the MAP Research Network. The program is sponsored by the Society and a grant from the National Institute of General Medical Sciences (GM095349). Participants gain research experience in laboratories at Baylor College of Medicine; University of California, San Diego; University of Colorado Health Sciences Center; University of Virginia; Emory University; and University of Wisconsin - Madison.

The second Power of A Silver Award went to the Society's diabetes policy summit. Held in September 2014, the event gathered more than 150 medical experts, policymakers and patient advocates together to discuss how the implementation of the Affordable Care Act (ACA) is affecting people with the condition. The event gave opinion leaders an opportunity to explore current challenges to treating and preventing diabetes as well as how the shift in health care policy may affect diabetes care and outcomes in the future. The program was supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. & Lilly USA, LLC; Lilly USA, LLC; Merck & Co., Inc.; Novo Nordisk Inc.; and sanofi-aventis U.S.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Restoring insulin sensitivity without TZD side effects